C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2004
12/16/2004	US20040252660 Method for controlling connections to a mobile station
12/16/2004	CA2529061A1 Antimicrobial polypeptides
12/16/2004	CA2528727A1 Immunomodulating compositions, uses therefor and processes for their production
12/16/2004	CA2526482A1 Peptide ligands of dendritic cells for nucleic acid vector targeting
12/15/2004	EP1486505A1 Angiotensin derivatives
12/15/2004	EP1485406A2 Highly homogeneous molecular markers for electrophoresis
12/15/2004	EP1485405A2 Melanin-concentrating hormone analogs
12/15/2004	EP1485345A2 Urokinase inhibitors, production and use thereof
12/15/2004	EP1485118A2 Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy
12/15/2004	EP1485116A2 Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth
12/15/2004	EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals
12/15/2004	EP1226160B1 Novel antiarrhythmic peptides
12/15/2004	CN1555383A Novel peptide, novel adsorbent, adsorption unit and adsorption method
12/15/2004	CN1555272A Compositions and methods for modulation of immune responses
12/15/2004	CN1554664A Compounds and methods for diagnosis of tuberculosis
12/14/2004	US6831099 Enzyme inhibition
12/14/2004	US6831066 Amyloid precursor proteins with improved bioavailability; for treament of Alzheimer's disease
12/14/2004	US6831065 Anti-inflammatory compounds and uses thereof
12/14/2004	US6831059 Compositions and methods for treating gonadotrophin related illnesses
12/14/2004	US6830894 Compounds and methods for modulating claudin-mediated functions
12/14/2004	US6830890 Nucleic acid probe libraries
12/14/2004	US6830883 Diagnosis/treatment/kits for anaemia/leukemia/immune deficiency diseases
12/09/2004	WO2004106366A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines
12/09/2004	WO2004106364A1 Stabilizing peptides and their use in the preparation of stabilized hiv inhibitors
12/09/2004	WO2004106359A2 Self-assembled peptide-amphiphiles & self-assembled peptide nanofiber networks presenting multiple signals
12/09/2004	WO2004028473A3 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
12/09/2004	WO2003082898A3 Novel analogues of glucose-dependent insulinotropic polypeptide
12/09/2004	WO2003014142A3 Phosphorylated histone h2b as an apoptosis marker
12/09/2004	US20040249586 Molecular modification assays
12/09/2004	US20040249152 Activation of the carboxyl function of a CNA monomer building block, subsequent esterification of this monomer building block with a free hydroxyl function,thereafter assembly of the oligomer by repetitive cycles starting from elimination of the protective group
12/09/2004	US20040249133 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours
12/09/2004	US20040249122 Cationic, amphipathic beta-sheet peptides and uses thereof
12/09/2004	US20040249121 Providing protected linear peptide, reacting protected peptide with acidic composition to produce semi-protected linear peptide with orthogonal protecting group on thiol-containing residues, purify peptide, treat with oxidizing agent, recover cyclic peptide such as octreotide, calcitonin, oxytocin
12/09/2004	US20040248831 Oligodeoxynucleic acid modified with (thio)phosphate
12/09/2004	US20040248810 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
12/09/2004	US20040248795 unlike calpastatin, the peptides of the invention do not target an active cysteine of calpain; protecting neurons against ultraviolet radiation induced cell death
12/09/2004	US20040248786 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/09/2004	US20040248783 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
12/09/2004	US20040248776 Intermediates and methods for making heptapeptide oxytocin analogues
12/09/2004	US20040248770 filtering of the antifungal agent, Caspofungin, through a zirconium-layered ceramic; reduces endotoxin levels
12/09/2004	US20040248765 Tumour targeting prodrugs activated by metallo matrixproteinases
12/09/2004	US20040248255 Leukocyte stimulating peptides
12/09/2004	US20040248229 Methods and kits for transferases
12/09/2004	US20040248194 Peptide screen
12/09/2004	US20040248162 Releasable polymer arrays
12/09/2004	US20040247612 Immunogenic peptide composition for the prevention and treatment of Alzheimer's Disease
12/09/2004	US20040247523 Diagnosing and localizing sites of inflammation and perfusion abnormalities (e.g. reperfusion injury, vulnerable plaque, bacterial endocarditis or cardiac transplant rejection) in a single dual isotope imaging procedure, particularly CT imaging, ultrasound, or scintigraphy.
12/09/2004	CA2527795A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines
12/08/2004	EP1484336A1 Methods for synthesizing conformationally constrained peptides, peptidometics and the use thereof as synthetic vaccines
12/08/2004	EP1483575A2 Methods for isolating ligands e.g. t cell epitopes
12/08/2004	EP1483290A2 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
12/08/2004	EP1483286A1 A process for the production of ramoplanin-like amide derivatives
12/08/2004	EP1482894A2 Cosmetic formulations containing l-arginine oligomers
12/08/2004	EP1214448A4 A rapid quantitative measurement of soluble fibrin in opaque body fluids
12/08/2004	EP1045858B1 Anti-cryptococcal peptides
12/08/2004	CN1554021A A novel cancer marker and uses therefor in the diagnosis of cancer
12/08/2004	CN1552894A Corn peptide and its preparation and use
12/08/2004	CN1552737A Process for the preparation of resin-bound cyclic peptides
12/08/2004	CN1552728A Amine synthetic method
12/08/2004	CN1552727A Targetted polypeptide for specificity of liver cancer blood vessel
12/08/2004	CN1179040C Cyclic peptides
12/07/2004	US6828417 For measurement of analytes to be measured in samples derived from living bodies, such as body fluids (e.g. serum, blood, plasma, urine, etc.), lymphocyte, hemocyte, and various cells
12/07/2004	US6828416 Recombinant multivalent malarial vaccine against Plasmodium falciparum
12/07/2004	US6828304 Lipid-peptide conjugates containing fatty acids of different sizes, which inhibits the binding of Vasoactive intestinal peptide to its receptor
12/07/2004	US6828302 Therapeutic uses of depsipeptides and congeners thereof
12/07/2004	US6827939 Amino acid sequences for use in detection and treatment of viral infection
12/07/2004	CA2217776C Synthetic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
12/02/2004	WO2004104594A2 Light emitting probes
12/02/2004	WO2004104039A2 Tumor antigens for prevention and/or treatment of cancer
12/02/2004	WO2004104031A2 Modified antiviral peptides with increased activity and cell membrane affinity
12/02/2004	WO2004104030A2 Peptides modulating the activity of the engrailed transcription factor
12/02/2004	WO2004104029A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer’s disease
12/02/2004	WO2004103266A2 Protein kinase c peptides for use in withdrawal
12/02/2004	WO2003102020A3 Carbon nanotube binding peptides
12/02/2004	WO2003073066A3 Reagents and methods for assaying bacillus anthracis lethal factor protease
12/02/2004	US20040242842 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
12/02/2004	US20040242490 CLK-peptide and SLK-peptide
12/02/2004	US20040242488 Peptides having same amino acid sequence and same anti-microbial activity as those of Phylloseptins which are isolated from the skin of Phyllomedusa hypochondrialis; the 19-residue anti-microbial peptides are cationic and based on their primary structure, all peptides can fitted to an amphiphilic a-helix
12/02/2004	US20040242479 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells
12/02/2004	US20040242476 Peptide and analogs thereof having an amino acid sequence corresponding to the second extracellular domain of a mammalian occludin; may be administered orally or parenterally
12/02/2004	US20040242474 High density lipoprotein-reactive peptides
12/02/2004	US20040242467 Contacting an aqueous solution of the lipopeptide antibiotic and a divalent metal ion with an organic solvent, thereby extracting the lipopeptide antibiotic into the organic solvent; andcontacting the organic solvent extract of the lipopeptide antibiotic with acid
12/02/2004	US20040241792 Substrates and assays for beta-secretase
12/02/2004	US20040241791 Protein hydrolysates enriched in peptides having a carboxy terminal proline residue
12/02/2004	US20040241782 Methods and means for detecting enzymatic cleavage and linkage reactions
12/02/2004	US20040241731 Methods of producing nucleic acid ligands
12/02/2004	US20040241664 Protein Hydrolysates Enriched In Peptides Having A Carboxy Terminal Proline Residue
12/02/2004	US20040241639 Human tachykinin-related splice variants and compositions thereof
12/02/2004	US20040241096 Detect enzyme activity in sample; incubation target tissue; detect amplification in sample
12/02/2004	CA2557625A1 Method of treatment of systemic injury secondary to burns
12/02/2004	CA2526654A1 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease
12/02/2004	CA2526069A1 Modified antiviral peptides with increased activity and cell membrane affinity
12/02/2004	CA2524818A1 Protein kinase c peptides for use in withdrawal
12/02/2004	CA2469528A1 Peptide and peptide mimetic derivatives having integrin inhibitor properties iii
12/02/2004	CA2466430A1 Process for the preparation of cyclic peptides
12/01/2004	EP1481059A1 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
12/01/2004	EP1481007A2 Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, treatments and animal models produced therefrom
12/01/2004	EP1481005A1 Dab sp 9 /sp DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME
12/01/2004	EP1481004A2 Streptavidin-binding peptide
12/01/2004	EP1481001A2 Prion inhibiting peptides and derivatives thereof

1 ... 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 ... 423